The increase in price target from $215 to $225 by Rosenblatt suggests a positive outlook on the company's value, despite maintaining a Neutral rating. This could indicate a belief in stable growth or undervaluation at current levels, which may lead to a slight positive investor sentiment in the short term. However, since the rating remains Neutral, the impact is likely to be moderate rather than significant.